Pediatric rheumatology in Turkey

Amra Adrovic1, Ozgur Kasapcopur2

  • 1Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Insights

Pediatric rheumatology in Turkey is growing, with common conditions like Familial Mediterranean fever and juvenile idiopathic arthritis being studied. Further research and international collaboration are needed to improve childhood rheumatic disease management.

Area of Science:

  • Pediatric Rheumatology
  • Auto-inflammatory Diseases
  • Rheumatic Diseases in Children

Background:

  • Pediatric Rheumatology is an emerging specialty in Turkey.
  • Increasing number of centers and specialists available nationwide.
  • Overview of pediatric rheumatology services and literature in Turkey.

Observation:

  • Systematic literature search conducted using PubMed/MEDLINE, Web of Science, and SCOPUS for the last 5 years.
  • Focus on the history of pediatric rheumatology in Turkey.
  • Emphasis on common rheumatologic conditions: Familial Mediterranean fever, juvenile idiopathic arthritis, juvenile spondyloarthropathies, and childhood vasculitides.

Findings:

  • Considerable literature exists on pediatric rheumatic diseases in Turkey.
  • Need for unique strategies to manage childhood rheumatic diseases.
  • Turkey's unique position for auto-inflammation and inflammatory condition research.

Implications:

  • Prospective, multicentric studies are essential for relevant data and improved disease management.
  • International collaborations and databases are encouraged to standardize pediatric rheumatic disease care.
  • Leveraging Turkey's cultural, historical, and geographical context for research in auto-inflammatory conditions.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
292